S
EOLS icon

SignatureFD’s Evolus EOLS Stock Holding History

SignatureFD’s Portfolio EOLS Stock Details EOLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-37
Closed -$246 – 3515
2025
Q4 		$246 Sell
37
-282
-88% -$1.91K ﹤0.01% 3287
2025
Q3 		$1.96K Buy
+319
New +$2.49K ﹤0.01% 2957
2024
Q2 		– Sell
-29
Closed -$406 – 3159
2024
Q1 		$406 Buy
+29
New +$377 ﹤0.01% 3050
2023
Q3 		– Sell
-94
Closed -$683 – 3223
2023
Q2 		$683 Buy
+94
New +$811 ﹤0.01% 3040
2022
Q4 		– Sell
-164
Closed -$1K – 3323
2022
Q3 		$1K Buy
164
+78
+91% +$827 ﹤0.01% 2949
2022
Q2 		$1K Buy
+86
New +$1.01K ﹤0.01% 2901
2020
Q1 		– Sell
-63
Closed -$1K – 2325
2019
Q4 		$1K Buy
+63
New +$888 ﹤0.01% 2016

Other funds holding EOLS

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SignatureFD's EOLS Position: Q1 2026 in Review

SignatureFD sold out of Evolus (EOLS) in Q1 2026, closing a stake of 37 shares — an estimated $246 sold.

SignatureFD first reported a position in EOLS in Q4 2019 and held it in 7 quarters. The position peaked at $1.96K in Q3 2025. 147 funds tracked by Wall St. Rank hold EOLS as of Q1 2026.

  • SignatureFD reported no remaining Evolus position as of Q1 2026 after selling out during the quarter.
  • SignatureFD sold 37 Evolus shares in Q1 2026, an estimated $246.
  • SignatureFD first reported a position in Evolus in Q4 2019 and held it in 7 quarters.
  • SignatureFD's Evolus position peaked at $1.96K in Q3 2025.
  • 147 funds tracked by Wall St. Rank held Evolus as of Q1 2026.

Based on SignatureFD's 13F filing for Q1 2026, filed 7 Apr 2026.